Interview with AION Labs CTO: How AL/ML are transforming drug discovery and development Post date May 2, 2022 ← AIThority: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies → AION Labs nominated for Prix Galien award!